Skip to main content
TipRanks
Go Ultimate75% OFF

MT Genex Corporation (9820) AI Stock Analysis

0 Followers
JP:9820

MT Genex Corporation

(TSE/TYO:9820)

Select Model
Rating:81Outperform
Price Target:JPY 5,018.00â–²(15.49% Upside)
Action:reiterated
Date:11/14/26

Strong financial performance from robust balance sheet and revenue growth is the primary driver, supported by bullish technical momentum and attractive low P/E valuation.

Positive Factors
Strong Revenue GrowthAccelerating revenue growth indicates expanding business activity and supports the company’s ability to build scale. If maintained, stronger sales can provide a durable platform for reinvestment, operating leverage, and improved earnings capacity over the next several quarters.
Negative Factors
Weak Cash ConversionLow operating cash conversion means reported earnings are not consistently translating into cash from core operations. Working-capital drag or similar pressure could constrain self-funded growth and make liquidity generation more volatile over the next several quarters.

MT Genex Corporation (9820) vs. iShares MSCI Japan ETF (EWJ)

-5%0%5%10%15%20%25%30%JP:9820+26.81%EWJ+18.48%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 4.68B
Dividend Yield
0.92%
Average Volume (3M)
1,092
Price to Earnings (P/E)
7.2
Beta (1Y)
0.38
Revenue Growth
64.24%
EPS Growth
142.31%
Country
Japan
Employees
151
Sector
General
Sector Strength
55
Industry
Engineering & Construction

MT Genex Corporation Business Overview & Revenue Model

Company Description

MT Genex Corporation, along with its group of companies, serves as a specialist contractor for both new construction and refurbishment of homes and commercial premises throughout Japan. Its activities are structured across four primary divisions: Ren...

MT Genex Corporation Financial Statement Overview

Summary

Strong balance sheet with minimal debt-to-equity at 0.019 and equity at 4.40 billion, plus accelerating revenue growth to 15.8%, offset by cash flow volatility.

Income Statement

82Very Positive

Balance Sheet

92Very Positive

Cash Flow

65Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2026Mar 2025Mar 2024Mar 2023
Income Statement
Total Revenue4.17B3.95B4.71B3.79B3.26B2.97B
Gross Profit966.70M925.84M1.10B913.35M806.26M762.43M
EBITDA486.61M496.96M535.60M488.79M409.52M373.73M
Net Income259.32M264.99M314.86M277.57M241.66M212.62M
Balance Sheet
Total Assets5.12B5.12B5.65B5.01B4.76B4.59B
Cash, Cash Equivalents and Short-Term Investments2.19B2.01B1.99B1.84B1.83B1.85B
Total Debt93.49M102.33M84.66M171.23M181.80M251.47M
Total Liabilities925.45M995.44M1.25B1.10B1.09B1.11B
Stockholders Equity4.19B4.13B4.40B3.91B3.68B3.48B
Cash Flow
Free Cash Flow0277.26M54.99M257.94M76.61M388.92M
Operating Cash Flow0295.30M79.43M288.99M122.53M394.85M
Investing Cash Flow0-11.81M-31.95M-183.88M-22.49M-1.46M
Financing Cash Flow0-112.00M-60.88M-103.12M-112.62M-76.72M

MT Genex Corporation Technical Analysis

Technical Analysis SentimentPositive
Last Price4345.00

Price Trends

50DMA3752.30Positive
100DMA3703.90Positive
200DMA3643.84Positive

Market Momentum

MACD44.01Negative
RSI80.59Negative
STOCH98.14Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9820, the sentiment is Positive. The current price of 4345.00 is above the 20-day moving average (MA) of 3668.25, above the 50-day MA of 3752.30, and above the 200-day MA of 3643.84, indicating a bullish trend. The MACD of 44.01 indicates Negative momentum. The RSI at 80.59 is Negative, neither overbought nor oversold. The STOCH value of 98.14 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9820.

MT Genex Corporation Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:9820 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9820JP:982081OutperformJPY 4.68B7.20―0.92%64.24%142.31%
JP:3948JP:394863NeutralJPY 6.70B19.69―4.29%0.32%67.81%
JP:9087JP:908761NeutralJPY 4.13B21.28―1.74%6.19%-1.30%
JP:7916JP:791657NeutralJPY 5.58B-24.35―2.74%-3.13%-142.20%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:3958JP:395855NeutralJPY 3.15B15.38―3.66%-2.64%-19.41%
JP:7805JP:780554NeutralJPY 3.06B9.12―2.11%-1.49%-24.51%

* General Sector Average

Performance Comparison

0%25%50%75%JP:9820JP:3948JP:3958JP:7805JP:7916JP:9087Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:9820 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:9820MT Genex Corporation4345.00958.1628.29%
JP:3948Hikari Business Form Co., Ltd.1166.00-40.58-3.36%
JP:3958Sasatoku Printing Co.,Ltd.547.009.021.68%
JP:7805PRINTNET INC.617.00-26.35-4.10%
JP:7916Mitsumura Printing Co., Ltd.1823.00212.9713.23%
JP:9087Takase Corporation2014.00752.8659.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026